[go: up one dir, main page]

HN2006035238A - Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas - Google Patents

Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas

Info

Publication number
HN2006035238A
HN2006035238A HN2006035238A HN2006035238A HN2006035238A HN 2006035238 A HN2006035238 A HN 2006035238A HN 2006035238 A HN2006035238 A HN 2006035238A HN 2006035238 A HN2006035238 A HN 2006035238A HN 2006035238 A HN2006035238 A HN 2006035238A
Authority
HN
Honduras
Prior art keywords
derivatives
carbamoilbenzotriazol
phospholipases
lipases
inhibitors
Prior art date
Application number
HN2006035238A
Other languages
English (en)
Inventor
Petry Stefan
Zoller Gerhard
Tennagels Norbert
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HN2006035238A publication Critical patent/HN2006035238A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE BENZOTRIAZOL, SUS SALES DE UTILIDAD FARMACEUTICA Y SU USO COMO SUSTANCIAS MEDICINALES
HN2006035238A 2005-10-19 2006-10-18 Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas HN2006035238A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005049953A DE102005049953A1 (de) 2005-10-19 2005-10-19 Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen

Publications (1)

Publication Number Publication Date
HN2006035238A true HN2006035238A (es) 2010-05-24

Family

ID=37667178

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2006035238A HN2006035238A (es) 2005-10-19 2006-10-18 Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas

Country Status (26)

Country Link
US (2) US7897625B2 (es)
EP (1) EP1940807B1 (es)
JP (1) JP2009512650A (es)
KR (1) KR20080063474A (es)
CN (1) CN101291918A (es)
AR (1) AR057554A1 (es)
AU (1) AU2006303552A1 (es)
BR (1) BRPI0617613A2 (es)
CA (1) CA2625722A1 (es)
CR (1) CR9850A (es)
DE (1) DE102005049953A1 (es)
DO (1) DOP2006000226A (es)
EC (1) ECSP088377A (es)
GT (1) GT200600463A (es)
HN (1) HN2006035238A (es)
IL (1) IL190714A0 (es)
MA (1) MA29858B1 (es)
NO (1) NO20081942L (es)
NZ (1) NZ567573A (es)
PE (1) PE20070724A1 (es)
RU (1) RU2430096C2 (es)
TN (1) TNSN08177A1 (es)
TW (1) TW200730513A (es)
UY (1) UY29872A1 (es)
WO (1) WO2007045393A1 (es)
ZA (1) ZA200802370B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101541782A (zh) * 2006-10-04 2009-09-23 先灵公司 作为凝血酶受体拮抗剂的二环和三环衍生物
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
EP2351744B1 (en) * 2008-10-17 2015-01-07 Shionogi & Co., Ltd. Acetic acid amide derivative having inhibitory activity on vascular endothelial lipase
AR075111A1 (es) * 2008-12-24 2011-03-09 Bial Portela & Ca Sa Derivados heterociclicos de diazoles y triazoles, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de trastornos del metabolismo y del sistema nervioso, entre otros.
US8975286B2 (en) * 2009-08-20 2015-03-10 Merck Sharp & Dohme Corp. Ether benzotriazole derivatives
KR20120123325A (ko) 2009-12-15 2012-11-08 시오노기세야쿠 가부시키가이샤 혈관 내피 리파아제 저해 활성을 갖는 옥사디아졸 유도체
US8450350B2 (en) * 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
WO2012047580A1 (en) * 2010-09-27 2012-04-12 Janssen Pharmaceutica Nv Alpha-ketoamide derivatives useful endothelial lipase inhibitors
EP3019482B1 (en) 2013-02-25 2018-08-15 Aurigene Discovery Technologies Limited Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
RU2563254C2 (ru) * 2013-07-08 2015-09-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ получения производных 7-(гетеро)арил-4,5,6,7-тетрагидро[1,2,3]триазоло[1,5-a]пиридина
RU2553987C1 (ru) * 2013-12-26 2015-06-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный университет" (СПбГУ) N-адамантилбензотриазолы, проявляющие активность против вируса гриппа а, и способ их получения
CN104292172B (zh) * 2014-09-12 2016-08-17 浙江理工大学 一种苯并三氮唑类衍生物及其制备方法
HRP20211462T1 (hr) * 2017-04-24 2021-12-24 Aurigene Discovery Technologies Limited Postupci uporabe za trisupstituirane derivate benzotriazola kao inhibitora dihidroorotatne oksigenaze
US20180369206A1 (en) 2017-04-24 2018-12-27 Aurigene Discovery Technologies Limited Methods of Use for Trisubstituted Benzotriazole Derivatives as Dihydroorotate Oxygenase Inhibitors
ES3038736T3 (en) 2018-02-20 2025-10-14 Servier Lab Benzotriazole derivative for use in treating double and triple hit diffuse large b cell lymphoma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1035188A (en) * 1974-08-15 1978-07-25 Eastman Kodak Company Blocked development restrainers
US4273860A (en) * 1977-12-28 1981-06-16 Eastman Kodak Company Inhibition of image formation utilizing cobalt(III) complexes
CA1124716A (en) 1978-10-20 1982-06-01 Michael J. Simons Blocked benzotriazole compounds as development restrainer precursors
JPS6239573A (ja) * 1985-08-13 1987-02-20 Sumitomo Chem Co Ltd シクロアルケニルアミド誘導体、その製造法およびそれを有効成分とする土壌病害防除剤
US6440648B1 (en) * 2000-06-13 2002-08-27 Eastman Kodak Company Color photographic element having improved contrast and compatibility with both dry and conventional processing
US6372421B1 (en) * 2000-06-13 2002-04-16 Eastman Kodak Company Photothermographic imaging element having improved contrast and methods of image formation
MXPA03010129A (es) 2001-05-05 2004-03-10 Smithkline Beecham Plc N-aroilaminas-ciclicas.
EP1458374A2 (en) 2001-12-14 2004-09-22 Novo Nordisk A/S Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
DE10247680B4 (de) * 2002-10-12 2005-09-01 Aventis Pharma Deutschland Gmbh Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
ATE442139T1 (de) * 2003-03-31 2009-09-15 Lilly Co Eli 3-oxo-1,3-dihydro-indazol-2-carbonsäureamid derivate als phospholipase inhibitoren

Also Published As

Publication number Publication date
CN101291918A (zh) 2008-10-22
GT200600463A (es) 2007-05-21
EP1940807A1 (de) 2008-07-09
CA2625722A1 (en) 2007-04-26
CR9850A (es) 2008-06-18
WO2007045393A1 (de) 2007-04-26
AR057554A1 (es) 2007-12-05
ECSP088377A (es) 2008-05-30
UY29872A1 (es) 2007-05-31
KR20080063474A (ko) 2008-07-04
US20080287503A1 (en) 2008-11-20
AU2006303552A1 (en) 2007-04-26
US20110118321A1 (en) 2011-05-19
NO20081942L (no) 2008-04-23
EP1940807B1 (de) 2015-06-17
BRPI0617613A2 (pt) 2011-08-02
DE102005049953A1 (de) 2007-04-26
PE20070724A1 (es) 2007-08-07
DOP2006000226A (es) 2007-05-15
ZA200802370B (en) 2008-12-31
US7897625B2 (en) 2011-03-01
NZ567573A (en) 2010-06-25
JP2009512650A (ja) 2009-03-26
TW200730513A (en) 2007-08-16
RU2430096C2 (ru) 2011-09-27
MA29858B1 (fr) 2008-10-03
TNSN08177A1 (en) 2009-10-30
RU2008119460A (ru) 2009-11-27
IL190714A0 (en) 2008-11-03

Similar Documents

Publication Publication Date Title
HN2006035238A (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
UY31001A1 (es) Derivados de imidazolidinacarboxamida como inhibidores de lipasas y fosfolipasas
CR9851A (es) Derivados de triazolopiridina en calidad de inhibidores de lipasas y fosfolipasas
UY29853A1 (es) Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas-
HN2007000267A (es) Compuestos de 4-metil piridopirimidinoma
UY32626A (es) Inhibidores de beta-lactamasa
ECSP10010246A (es) Inhibidores de beta-lactamasa
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
EP2101745A4 (en) ADMINISTRATION OF MEDICINES
UY30226A1 (es) Composiciones farmacéuticas
CR10149A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico
BRPI0915300B8 (pt) compostos de éster boronato e composições farmacêuticas dos mesmos
CR11373A (es) COMPUESTOS DE TIENOPIRIMIDINA Y PIRAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE mTOR CINASA Y PI3 CINASA
GT200800209A (es) Compuestos organicos
BRPI0813105A2 (pt) Derivado de sulfonamida de ácido malônico e uso faramacêutico do mesmo
HN2012000263A (es) Derivados n1-sulfonil-5-fluoropirimidinona
ECSP10010015A (es) Inhibidores de proteasoma
CR20160475A (es) Derivados de ácido 1-amino-2-ciclobutiletilborónico
UY32605A (es) Agentes antiinflamatorios como compuestos virostáticos
HN2011001019A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk) produccion y uso de los mismos como productos medicinales
HN2006019513A (es) Inhibidores de la fosfolipasa a2 citosolica
UY31000A1 (es) Oxoisoxazoles como inhibidores de lipasas y fosfolipasas
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
EP2344533A4 (en) TMPRSS4-SPECIFIC HUMAN ANTIBODY
FR2940086B1 (fr) Formulation pharmaceutique de fenofibrate nanonise